Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition
Year: 2018
Type: erratum
Source: Nature Medicine
Authors: Gabrielle S. Wong, Jin Zhou, Jie Bin Liu, Zhong Wu, Xinsen Xu, Tianxia Li, David Xu, Steven E. Schumacher, Jens Puschhof, James McFarland, Charles Zou, Austin Dulak, Les Henderson, Peng Xu, Emily O’Day, Rachel Rendak, Wei-li Liao, Fabiola Cecchi, Todd Hembrough, Sarit Schwartz, Christopher Szeto, Anil K. Rustgi, Kwok-Kin Wong, J. Alan Diehl, Karin Jensen, Francesco Graziano, Annamaria Ruzzo, Shaunt Fereshetian, Philipp Mertins, Steven A. Carr, Rameen Beroukhim, Kenichi Nakamura, Eiji Oki, Masayuki Watanabe, Hideo Baba, Yu Imamura, Daniel Catenacci, Adam J. Bass
Institutions: Dana-Farber Cancer Institute, University of Chicago, University of Chicago Medical Center, Broad Institute, OncoPlex Diagnostics (United States), NantOmics LLC (United States), Abramson Cancer Center, University of Pennsylvania, Harvard University, NYU Langone Health, Medical University of South Carolina, University of Illinois Urbana-Champaign, University of Urbino, Max Delbrück Center, Brigham and Women's Hospital, Kumamoto University, Kyushu University, The Cancer Institute Hospital, Japanese Foundation For Cancer Research
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2885574074